Quick Takeaways
- Stuart Duty has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $208,000.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Stuart Duty
- Location
- Bothell, WA
- Summary
- The estimated net worth of Stuart Duty is at least $208,000 dollars as of 06 Jan 2026. Stuart Duty is the Director of Foghorn Therapeutics Inc. and owns shares of Foghorn Therapeutics Inc. (FHTX) stock worth about $208K.
- Signature
- /s/ Ron Honig, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Stuart Duty and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Foghorn Therapeutics Inc. ($208,000).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Stuart Duty
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc. | Director | $208,000 | 01 May 2025 | ||
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Director | 06 Jun 2025 | |||
| EYPT | EyePoint, Inc. | Director | 02 Jan 2026 | |||
| MIST | Milestone Pharmaceuticals Inc. | Director | 10 Jun 2025 |
Insider Transactions Reported by Stuart Duty:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.